Instalab
logoInstalab

Latex (Hev b 1) IgE

Blood Test
Pinpoint whether your latex reactions trace back to the single protein that drives most severe cases in high-exposure groups.
4.9 (4,173 reviews)
Tested by Diagnostic Solutions Lab
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Latex (Hev b 1) IgE test?

This test is most useful if any of these apply to you.

Born with Spina Bifida
This test can identify whether the latex protein most often responsible for serious surgical reactions in your group is one you react to.
Working in Healthcare
If you suspect latex glove exposure is causing skin or breathing symptoms at work, component testing helps map which proteins drive your reaction.
Multiple Past Surgeries
Repeated medical exposure to latex in childhood is a strong driver of this specific antibody, and knowing your status guides safer future procedures.
Reacted During a Medical Procedure
If you have ever had unexplained hives, swelling, or breathing trouble during surgery or a dental visit, this test helps rule latex in or out.

About Latex (Hev b 1) IgE

If you grew up with multiple surgeries, work in healthcare, or had an unexplained reaction during a medical procedure, latex is one of the quieter triggers worth ruling in or out. This test measures whether your immune system has made antibodies against a specific latex protein called Hev b 1, which is often the dominant sensitizer in people exposed to latex through surgery and medical care, particularly those with spina bifida.

Crude latex allergy panels lump every latex protein together, which can leave you guessing whether a positive result reflects a real risk or a harmless cross-reaction. Testing for Hev b 1 specifically helps separate true clinical allergy in high-exposure groups from background sensitization that may never cause symptoms.

What This Test Actually Measures

Hev b 1 IgE (immunoglobulin E, a type of antibody your immune system makes when it learns to react to something) is one of several antibodies you can make against natural rubber latex. Hev b 1 itself, also called rubber elongation factor, is a 14.6 kDa protein found on the surface of large rubber particles in latex from the rubber tree. When you get exposed to latex through gloves, catheters, or surgical materials, certain immune cells can switch on and start producing IgE antibodies that recognize this protein.

A blood test detects these antibodies in your serum. A positive result means your immune system has been primed against Hev b 1. It does not automatically mean you will have a severe reaction the next time you touch a latex glove. Sensitization (having the antibody) and clinical allergy (actually reacting) are related but not identical, and this distinction shapes how the result should be interpreted.

Latex Allergy in People with Spina Bifida

This is where Hev b 1 IgE matters most. People with spina bifida often go through many surgeries early in life, and that repeated exposure to latex gloves and medical devices appears to drive a very specific pattern of allergic sensitization. Hev b 1 is frequently a dominant latex protein their immune system has learned to recognize, alongside Hev b 3, which also plays an important role in this population.

In one study of latex-allergic spina bifida patients, about 81% had detectable IgE against Hev b 1. When researchers added purified Hev b 1 to blood samples to see how much of the latex reactivity it accounted for, it completely blocked IgE binding to whole latex extract in nearly half of those tested (15 of 33 sera), and accounted for more than half of the binding in most of the rest. In other words, for a large share of these patients, Hev b 1 was essentially the entire allergic story.

Cumulative surgical exposure drives the pattern. Children with a history of multiple operations have shown around 67% Hev b 1 IgE positivity compared with only about 27% in children without surgical history. If you or your child has had multiple procedures involving latex contact, Hev b 1 is one of the most informative single markers you can check.

Occupational Latex Allergy in Healthcare Workers

Healthcare workers tell a different story. In this group, latex sensitization happens through repeated glove use, but the proteins driving the allergic response are usually different. Hev b 5, Hev b 6.01, and Hev b 6.02 are consistently the dominant allergens, with Hev b 13 also identified as a major in vivo allergen in some studies (though its prevalence varies with the protein preparation used). Hev b 1 plays a smaller role in most healthcare workers.

Reported rates of Hev b 1 positivity in latex-allergic healthcare workers vary widely by method. Some studies using highly purified Hev b 1 have reported rates above 50%, while recombinant component assays often show lower rates. Either way, it is generally not the main driver of occupational latex allergy. If you are a healthcare worker investigating glove-related symptoms, testing Hev b 1 alone could give an incomplete picture. The other Hev b components often matter more in your context.

Reconciling the Two Patterns

It can be confusing that the same biomarker is highly informative in one group and a smaller part of the picture in another. The reason is that latex allergy is not one disease with one pathway. It is several different sensitization patterns shaped by how, when, and where you encountered latex. Surgical exposure through mucous membranes in early childhood favors Hev b 1 and Hev b 3 sensitization. Skin and airway exposure to glove powder in adulthood favors Hev b 5 and Hev b 6. The right interpretation of a Hev b 1 result depends entirely on knowing which exposure history applies to you.

Connection to Anaphylaxis and Severe Reactions

Latex is a recognized cause of anaphylaxis, especially during surgery and obstetric procedures. In large UK anesthesia data (the NAP6 audit), latex accounted for a very small share of peri-operative anaphylaxis cases, with zero confirmed latex cases among 266 Grade 3–5 reactions; neuromuscular blocking drugs and antibiotics dominated. French data show a similar pattern, with neuromuscular blockers at around 60% and antibiotics at around 25%, and latex not among the top causes. The declining incidence reflects widespread adoption of non-latex alternatives in modern operating rooms.

A key thing to understand: a high Hev b 1 IgE level does not guarantee you will have a severe reaction, and a low or borderline level does not guarantee you are safe. Across allergens in general, the level of specific IgE alone is a poor predictor of how severe a future reaction will be. Severity is shaped by many other factors, including coexisting asthma, exercise, alcohol, and certain medications. Treat this test as one input in a broader risk picture, not as a verdict.

Distinguishing True Allergy from Background Sensitization

One of the most useful things component testing does is separate genuine clinical allergy from what is sometimes called silent sensitization. Many people have positive whole-latex IgE tests but never actually react to latex. A common reason is isolated sensitization to Hev b 8, a latex protein called profilin that cross-reacts with pollens and many plant foods. In one study of grass pollen-sensitized individuals, around 9.4% showed IgE sensitization to natural rubber latex, but only about 1.6% had confirmed type I allergy, and cross-reactive carbohydrate determinants together with Hev b 8 explained clinically irrelevant sensitization in roughly 65% of cases. People sensitized only to Hev b 8 often have no latex symptoms at all, even though their crude latex IgE looks positive.

Testing for Hev b 1, alongside other major components like Hev b 5 and Hev b 6.02, helps clarify which pattern you actually have. A positive Hev b 1 in someone with a relevant surgical history points toward true allergy. A positive whole-latex IgE driven only by Hev b 8 in someone with pollen allergies typically does not.

Why One Reading Is Not Enough

Allergen-specific IgE levels fluctuate over time as exposure changes, immune activity shifts, and other factors come into play. The level you measure today is a snapshot, not a permanent fixture. If you are actively avoiding latex, levels can drift downward over months. If you are still being exposed, the level may climb.

A reasonable approach, based on common clinical practice rather than formal guideline recommendations: get a baseline test now if you have a relevant history, then consider retesting in 6 to 12 months if you are making meaningful exposure changes (switching to non-latex gloves at work, avoiding latex products at home) or if your symptom pattern shifts. For anyone with a confirmed allergy, periodic monitoring can make sense, especially if you are still in an environment with potential exposure. A single number should never be the only basis for an avoidance plan or a medical alert.

When Results Can Be Misleading

Several things can complicate the read on a Hev b 1 IgE result. The most important confounders are biological and methodological.

  • Cross-reactive sensitizations: if you are sensitized to Hev b 8 (latex profilin) through pollen exposure, a crude latex IgE test can look positive even though Hev b 1 itself may be negative or borderline. The two findings mean very different things clinically.
  • Population context: the same Hev b 1 number means different things depending on whether you are a person with spina bifida, a healthcare worker, or someone with no clear exposure history. Without that context, the number is hard to interpret.
  • Borderline values: low-level positives near the assay cutoff should not be over-interpreted, especially without a matching clinical story.
  • Carbohydrate cross-reactive determinants: sugar structures shared across many plants can produce false positive signals on some latex IgE assays, muddying the result.

What to Do If Your Result Is Positive

A positive Hev b 1 IgE is a signal to dig deeper, not a final diagnosis. The next steps depend on your exposure history and symptoms. If you have a clear story of latex reactions plus a high Hev b 1 IgE and a relevant surgical history, the picture lines up and avoidance plus a medical alert plan becomes the priority. If you have no symptoms but a positive Hev b 1 from a screening panel, you need more information before making decisions.

Useful complementary workup: a broader latex component panel (which typically includes Hev b 3, 5, 6.01, 6.02, and 8 as the most clinically informative components) to map out your sensitization pattern, a skin prick test for direct functional confirmation, and in some cases a basophil activation test, which measures whether your immune cells actually respond when exposed to latex. An allergist or immunologist can assemble these pieces into a coherent answer. For pre-operative planning, document your status clearly and discuss latex-free protocols with your surgical team well in advance.

How This Fits Into a Larger Latex Workup

Hev b 1 IgE is a piece of a larger puzzle, not the whole picture. The most informative latex workups combine total latex IgE (the broad screen), several individual Hev b components (to characterize the pattern), skin prick testing (for functional confirmation), and clinical history (the essential context). Each piece corrects the others. Whole-latex IgE alone over-calls allergy. Component testing alone without history under-explains it. Skin testing alone can miss subtle sensitizations. Used together, they give you a much clearer view of whether latex is a real problem for you and how careful you need to be.

Frequently Asked Questions

References

18 studies
  1. Chen Z, Cremer R, Posch a, Raulf-heimsoth M, Rihs H, Baur XThe Journal of Allergy and Clinical Immunology1997
  2. Ylitalo L, Alenius H, Turjanmaa K, Palosuo T, Reunala TThe Journal of Allergy and Clinical Immunology1998
  3. Pamies R, Oliver F, Raulf-heimsoth M, Rihs H, Barber D, Boquete M, Nieto a, Mazon aPediatric Allergy and Immunology2006
  4. Bernstein D, Biagini R, Karnani R, Hamilton R, Murphy K, Bernstein CK, Arif S, Berendts B, Yeang HThe Journal of Allergy and Clinical Immunology2003
  5. Ebo D, Hagendorens M, De Knop K, Verweij M, Bridts C, De Clerck LS, Stevens WClinical & Experimental Allergy2010